Aravax Establishes Pharmaceutical Development Base on the Oxford Science Park With a Focus on Developing Manufacturing Capabilities in the UK Drug Development & Delivery 14 November 2024 View news
Aravax’s Phase 2 Study Now Enrolling Children with Peanut Allergy SnackSafely.com 21 May 2024 View article
Check Up: Aussie biotech Avarax on the verge of peanut allergy cure STOCKHEAD 15 February 2024 View article
Aravax secures US$22M to close series B for peanut allergy therapy BioWorld 29 January 2024 View news [behind a paywall]
Groundbreaking peanut allergy therapy Food & Beverage Industry News 25 January 2024 View news
Aravax raises AU$66m for peanut allergy cure as Victoria leads the way Business News Australia 24 January 2024 View news
Made In Victoria: A Groundbreaking Peanut Allergy Therapy victoria.gov.au 23 January 2024 View news
Could this peanut allergy drug open up a US$4 billion market? Forbes 1 September 2023 View article
Aravax raises US$20M series B round to take peanut allergy immunotherapy to phase II BioWorld 27 December 2022 View news [behind a paywall]
Celebrating Scientists and Researchers – Dr Sara Prickett Australian Food Allergy Foundation 26 January 2017 View video
